1.990USD-2.93%Mkt Cap: 101.14M USDP/E: —Last update: 2026-05-26
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care product…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
54.95BSEKP/E 101.9
53.92BSEKP/E 22.9
52.13BDKKP/E 22.1
50.54BUSDP/E 47.4
39.31BEURP/E 18.6
Indicators:|
Key Statistics
Company
Market Cap101.14M USD
Enterprise Value75.76M USD
Revenue (TTM)34.38M USD
Gross Profit1.05M USD
Net Income (TTM)-47.12M USD
Revenue/Share0.7630 USD
Last Price1.990 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees171
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.61
PEG—
EV/EBITDA-1.62
EV/Revenue2.20
P/S3.00
P/B4.61
EPS (TTM)-1.10
EPS (Forward)-0.79
52W Range
1.9003% of range4.940
52W High4.940 USD
52W Low1.900 USD
Profitability
Gross Margin3.12%
Oper. Margin-173.11%
EBITDA Margin-136.37%
Profit Margin-140.30%
ROE-141.91%
ROA-62.95%
Growth
Revenue Growth11.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.06M USD
CapEx (TTM)850.00K USD
FCF Margin—
FCF Yield—
Net Debt-18.29M USD
Net Debt/EBITDA0.39
Balance Sheet
Debt/Equity0.72
Current Ratio2.58
Quick Ratio1.53
Book Value/Sh0.4490 USD
Cash/Share0.5050 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)8.000 USD
Target Range8.000 USD – 8.000 USD
# Analysts3
Ownership
Shares Out.45.32M
Float27.21M
Insiders9.90%
Institutions54.21%
Short Interest
Short Ratio4.2d
Short % Float3.04%
Short % Out.1.77%
Shares Short808.90K
Short (prev mo.)377.50K
Technical
SMA 502.369 (-16.0%)
SMA 2003.208 (-38.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)175.54K
Avg Vol (10d)208.34K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—